The pro-tumorigenic responses in metastatic niches: an immunological perspective

Mohammad Hossein Mirzapour1,2, Mahsa Heidari-Foroozan2,3, Sepideh Razi2,4,5

  • 1School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.

Insights

Cancer cells create pre-metastatic niches by altering secondary sites, often involving immune cells. This review details how immune and stromal cells promote cancer metastasis.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Metastasis, the spread of cancer, is the primary cause of cancer-related deaths.
  • Cancer cell dissemination involves detachment, circulation, extravasation, and colonization.
  • Tumor cells can pre-condition distant sites, forming pre-metastatic niches that enhance metastasis.

Purpose of the Study:

  • To review the mechanisms by which cancer cells induce and maintain pre-metastatic niches.
  • To highlight the significant roles of immune cells in facilitating metastasis.
  • To explore the contributions of stromal and endothelial cells in niche formation.

Main Methods:

  • Literature review of studies on pre-metastatic niche formation.
  • Analysis of the roles of innate and adaptive immune cells in metastasis.
  • Examination of stromal and endothelial cell involvement in supporting tumor cell dissemination.

Main Results:

  • Immune cells (innate and adaptive) are crucial for enhancing tumor cell recruitment, extravasation, and colonization.
  • Stromal cells and endothelial cells actively assist in the development of pre-metastatic niches.
  • Pre-metastatic niche formation significantly increases the probability of successful cancer cell dissemination.

Conclusions:

  • Pre-metastatic niche formation is a critical step in cancer metastasis.
  • Immune cells play a central role in orchestrating the pre-metastatic microenvironment.
  • Targeting immune and stromal cell interactions may offer therapeutic strategies to inhibit metastasis.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
643
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.7K
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.2K